(Q48267783)

10 February 2018

title

Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty (English)

1 reference

10 February 2018

author name string

Lentz RD

1

1 reference

10 February 2018

Bergstein J

2

1 reference

10 February 2018

Steffes MW

3

1 reference

10 February 2018

Brown DR

4

1 reference

10 February 2018

Prem K

5

1 reference

10 February 2018

Michael AF

6

1 reference

10 February 2018

Vernier RL

7

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 September 1977

1 reference

10 February 2018

The Journal of Pediatrics

published in

1 reference

10 February 2018

volume

91

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

385-394

1 reference

10 February 2018

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Minimal change and focal sclerotic lesions in lipoid nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide: Use in Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Drug therapy. Immunosuppressive agents. I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Drug therapy: immunosuppressive agents (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Sterility and testicular atrophy related to cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide and reproductive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Testicular atrophy in a prepubescent male after cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide and the prepubertal gonad: a negative report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Cyclophosphamide-Induced Ovarian Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Radioimmunoassay for human follicle-stimulating hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Radioimmunoassay for Human Follicle Stimulating Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

A radioimmunoassay for plasma testosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Rapid simultaneous radioimmunoassay for triiodothyronine and thyroxine in unextracted serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

The relationship of concentrations of serum hormones to pubertal gynecomastia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Gonadal dysfunction in uremic men. A study of the hypothalamo-pituitary-testicular axis before and after renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

7 January 2021

6 Delayed adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Unilateral cryptorchidism; subsequent effects on fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Histology of the maldescended testis at operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Reproductive Capacity of Dairy Bulls. IX. Changes in Reproductive Organ Weights and Semen Characteristics of Holstein Bulls During the First Thirty Weeks After Puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Return of spermatogenesis after stopping cyclophosphamide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Evidence for a Specific Seminiferous Tubular Factor Affecting Follicle-Stimulating Hormone Secretion in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

The Relationship Between Germinal Cells and Serum FSH Levels in Males with Infertility1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Gonadotropin Response to Luteinizing Hormone-Releasing Hormone in Men with Germinal Aplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

A Cycle of Plasma Testosterone in the Human Male

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Elucidation of mechanism(s) of the nocturnal rise of testosterone in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Correlation of serum follicular stimulating hormone (FSH) and luteinizing hormone (LH) as measured by radioimmunoassay in disorders of sexual development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Serum gonadotropin, testosterone and prolactin concentrations throughout puberty in boys: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

A Diphasic Pattern of Gonadotropin Secretion in Patients with the Syndrome of Gonadal Dysgenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Gonadotropin responses to luteinizing releasing factor in boys treated with cyclophosphamide for nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2981305-X

10.1016/S0022-3476(77)81305-X

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018